Yu Huang

Title: Yu Huang: Innovator in Therapeutic Antibody Development

Introduction

Yu Huang is a prominent inventor based in Ossining, NY (US), known for his significant contributions to the field of therapeutic monoclonal antibodies. With a total of 5 patents, he has made remarkable strides in understanding and improving antibody therapies.

Latest Patents

Among his latest patents, one notable invention focuses on the quantitation and modeling of quality attributes of therapeutic monoclonal antibodies. This patent provides methods for predicting an in vivo serum concentration of an antibody with a post-translational modification of interest after administration. The methods include predicting the percentage of the antibody with the modification and determining its concentration based on in vivo data. Another significant patent involves therapeutic uses of anti-GITR antibodies, which specifically bind to the glucocorticoid-induced tumor necrosis factor receptor (GITR). This patent outlines the antibodies, their compositions, and methods for treatment using these innovative therapies.

Career Highlights

Yu Huang has worked with notable companies in the pharmaceutical industry, including Regeneron Pharmaceuticals, Inc. His experience in these organizations has contributed to his expertise in antibody development and therapeutic applications.

Collaborations

Throughout his career, Yu Huang has collaborated with esteemed colleagues such as Robert Babb and Drew Dudgeon. These partnerships have further enhanced his research and development efforts in the field of therapeutic antibodies.

Conclusion

Yu Huang's innovative work in the realm of therapeutic monoclonal antibodies showcases his dedication to advancing medical science. His patents and collaborations reflect a commitment to improving treatment options for patients.